Virtu KCG Holdings’s CapForce IBD 50 ETF FFTY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
Sell
-18,042
Closed -$462K 3055
2017
Q1
$462K Buy
18,042
+4,476
+33% +$112K 0.01% 1466
2016
Q4
$328K Buy
+13,566
New +$317K 0.01% 1980
2016
Q3
Sell
-10,294
Closed -$221K 3187
2016
Q2
$221K Sell
10,294
-26,323
-72% -$554K ﹤0.01% 2217
2016
Q1
$773K Buy
+36,617
New +$739K 0.02% 782
2015
Q3
Sell
-16,568
Closed -$416K 3484
2015
Q2
$416K Buy
+16,568
New +$415K 0.01% 1669

Other funds holding FFTY

Virtu KCG Holdings's FFTY Position: Q2 2017 in Review

Virtu KCG Holdings sold out of CapForce IBD 50 ETF (FFTY) in Q2 2017, closing a stake of 18,042 shares — an estimated $462K sold.

Virtu KCG Holdings first reported a position in FFTY in Q2 2015 and held it in 5 quarters. The position peaked at $773K in Q1 2016. 18 funds tracked by Wall St. Rank hold FFTY as of Q2 2017.

  • Virtu KCG Holdings reported no remaining CapForce IBD 50 ETF position as of Q2 2017 after selling out during the quarter.
  • Virtu KCG Holdings sold 18,042 CapForce IBD 50 ETF shares in Q2 2017, an estimated $462K.
  • Virtu KCG Holdings first reported a position in CapForce IBD 50 ETF in Q2 2015 and held it in 5 quarters.
  • Virtu KCG Holdings's CapForce IBD 50 ETF position peaked at $773K in Q1 2016.
  • 18 funds tracked by Wall St. Rank held CapForce IBD 50 ETF as of Q2 2017.

Based on Virtu KCG Holdings's 13F filing for Q2 2017, filed 11 Aug 2017.